News
📈 Stocks
Biotech IPO Market Faces Scrutiny as 8 Firms Seek Capital for Clinical Trials
(just now)
Investors are prioritizing clinical-stage biotechs with proven potential, as eight companies navigate the IPO process with varying degrees of market readiness and…